Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study

This palliative RT regimen was highly tolerable and effective in preserving or improving self-reported QOL in most patients for up to 6 months, which corresponds to this population's median overall survival. Given the minimal side effects, intensification could be considered to achieve longer locoregional control.